DBV Technologies (DBVT) Shares Outstanding (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Shares Outstanding (Entity) of $433.5 million for Q2 2026, up 216.51% year-on-year from $137.0 million in Q2 2025, and up 1.22% on a QoQ basis from $428.3 million in Q1 2026.
DBV Technologies (DBVT) Shares Outstanding (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Shares Outstanding (Entity) for 12 consecutive years, with $433.5 million the latest figure, recorded in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 216.51% year-over-year to $433.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $433.5 million (up 216.51% YoY) and the FY2025 annual result came in at $139.6 million, up 35.71% from the prior year.
- Shares Outstanding (Entity) improved to $433.5 million in Q2 2026 per DBVT's latest filing, from $428.3 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for DBVT reached as high as $433.5 million in Q2 2026 and fell as low as $5.5 million in Q1 2022.
- A 5-year average of $88.7 million and a median of $14.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 0.29% — and 2025, when it jumped 966.62%.
- Year by year, Shares Outstanding (Entity) stood at $7.7 million in 2022, then climbed by 24.61% to $9.6 million in 2023, then jumped by 966.53% to $102.8 million in 2024, then surged by 35.71% to $139.6 million in 2025, then jumped by 210.61% to $433.5 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $433.5 million, $428.3 million, and $139.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 433.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 433.54 Mn |
| Mar 31, 2026 | 428.30 Mn |
| Dec 31, 2025 | 139.57 Mn |
| Sep 30, 2025 | 136.81 Mn |
| Jun 30, 2025 | 134.48 Mn |
| Mar 31, 2025 | 102.62 Mn |
| Dec 31, 2024 | 97.00 Mn |
| Sep 30, 2024 | 19.24 Mn |
| Jun 30, 2024 | 19.23 Mn |
| Mar 31, 2024 | 9.62 Mn |
| Dec 31, 2023 | 9.51 Mn |
| Sep 30, 2023 | 9.61 Mn |
| Jun 30, 2023 | 9.43 Mn |
| Mar 31, 2023 | 9.40 Mn |
| Dec 31, 2022 | 7.74 Mn |
| Sep 30, 2022 | 9.39 Mn |
| Jun 30, 2022 | 6.60 Mn |
| Mar 31, 2022 | 5.49 Mn |
| Dec 31, 2021 | 5.49 Mn |
| Sep 30, 2021 | 5.49 Mn |